4,873 Items Subject to Drug Re-Evaluation Reviews

Published: 2005-01-12 06:59:00

Updated: 2005-01-12 06:59:00

The Korea Food and Drug Administration (KFDA) has released the list of pharmaceutical items subject to this year's re-evaluation reviews on 4,873 items from 4 therapeutic groups with 21 subcategories.

Of the total 4,873 items, the majority of them subject to the upcoming reviews is the tonic ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK